1. Global Burden of Diseases (GBD). Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385 (9963):117-71. doi: 10.1016/S0140-6736(14)61682-2.
2. Feigin VL, Krishnamurthi RV, Parmar P, et al. Global Burden of Diseases (GBD). 2013 Writing Group; GBD 2013 Stroke Panel Experts Group. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015;45(3):161-76. doi: 10.1159/000441085.
3. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinical identifiable subtypes of cerebral infarction. The Lancet. 1991;337(8756):1521–1526. doi: 10.1016/0140-6736(91)93206-o.
4. Barker-Collo S, Bennett DA, Krishnamurthi RV, et al. GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013. Neuroepidemiology. 2015;45(3):203-14. doi: 10.1159/000441103.
5. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics —2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published correction appears in circulation. 2009; 119: e182]. Circulation. 2009; 119:480-6. doi: 10.1161/CIRCULATIONAHA.108.191259.
6. Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–-2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80.
7. Rita V Krishnamurthi 1, Andrew E Moran, Valery L Feigin, et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study. Neuroepidemiology, 2015. 45(3): p. 190-202. doi: 10.1159/000441098.
8. Kissela BM, Khoury JC, Alwell K, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012; 79:1781–1787. doi: 10.1212/WNL.0b013e318270401d.
9. George MG, Tong X, Kuklina EV, Labarthe DR. Trends in stroke hospi- talizations and associated risk factors among children and young adults, 1995-2008. Ann Neurol. 2011; 70:713-21. doi: 10.1002/ana.22539.
10. Williams PT. Reduction in incident stroke risk with vigorous physical activity: evidence from 7.7-year follow-up of the National Runners’ Health Study. Stroke. 2009; 40:1921-3. doi: 10.1161/STROKEAHA.108.535427.
11. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet. 2006;367(9524):1747–1757.doi:10.1016/S0140-6736(06)68770-9.
12. Flossmann E, Schulz U, Rothwell P. Systematic review of methods and results of studies of
the genetic epidemiology of ischemic stroke. Stroke. 2004; 35:212–27.
13. Scarborough P, Morgan RD, Webster P, et al. Differences in coronary heart disease, stroke and cancer mortality rates between England, Wales, Scotland and Northern Ireland: the role of diet and nutrition. BMJ Open. 2011;1(1):e000263. doi: 10.1136/bmjopen-2011-000263.
14. O’Donnell MJ, Chin SL, Rangarajan S, et al; INTERSTROKE Investigators. Global and regional effects of poten- tially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388:761–775. doi: 10.1016/S0140-6736(16)30506-2.
15. Chiuve SE, Rexrode KM, Spiegelman D, et al. Primary prevention of stroke by healthy lifestyle. Circulation. 2008;118(9):947-54. doi: 10.1161/CIRCULATIONAHA.108.781062.
16. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: John Wiley and Sons; 1989.
17. Hosmer DW, Lemeshow S. Applied logistic regression. 3rd ed. New York: John Wiley and Sons; 2000.
18. El Tallawy HN, Farghaly WM, Badry R, et al. Epidemiology and clinical presentation of stroke in Upper Egypt (desert area). Neuropsychiatr Dis Treat. 2015;11:2177-83. doi: 10.2147/NDT.S87381.
19. Marián Muchada, Marta Rubiera, David Rodriguez-Luna, et al. Baseline National Institutes of Health Stroke Scale–Adjusted. Time Window for Intravenous Tissue-Type Plasminogen. Activator in Acute Ischemic Stroke. Stroke. 2014; 45(4):1059-63. doi: 10.1161/STROKEAHA.113.004307.
20. Fabris F, Zanocchi M, Bo M, et al. Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke. 1994;25(6):1133-40. doi: 10.1161/01.str.25.6.1133.
21. Knoflach M, Matosevic B, Rücker M, et al. Austrian Stroke Unit Registry Collaborators. Functional recovery after ischemic stroke--a matter of age: data from the Austrian Stroke Unit Registry. Neurology. 2012;78(4):279-85. doi: 10.1212/WNL.0b013e31824367ab.
22. Choi JC, Lee JS, Kang SY, Kang JH, Bae JM. Family history and risk for ischemic stroke: sibling history is more strongly correlated with the disease than parental history. J Neurol Sci. 2009;284(1-2):29-32. doi: 10.1016/j.jns.2009.03.015.
23. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004;35(1):212-27. doi: 10.1161/01.STR.0000107187.84390.AA.
24. Altafi D, Khotbesara M, Khotbesara M, Bagheri A. A comparative study OF NIHSS between ischemic stroke patients with and without risk factors. Tech J Eng Appl Sci. 2013;3(17):1954-7.
25. Soliman RH, Oraby MI, Fathy M, et al. Risk factors of acute ischemic stroke in patients presented to Beni-Suef University Hospital: prevalence and relation to stroke severity at presentation. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):8. doi: 10.1186/s41983-018-0012-4.
26. Patlolla SH, Lee HC, Noseworthy PA, et al. Impact of Diabetes Mellitus on Stroke and Survival in Patients With Atrial Fibrillation. Am J Cardiol. 2020;131:33-39. doi: 10.1016/j.amjcard.2020.06.049.
27. Essa A, Helmy T, El Batch S. Study of incidence, risk factors and outcome of acute
cerebrovascular stroke patients admitted to Alexandria Main University Hospital. J Am Sci. 2011;7(11):316-29.
28. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol.
2005;105(3):315-8. doi: 10.1016/j.ijcard.2005.02.050.
29. Fohtung RB, Rich MW. Identification of patients at risk of stroke from atrial fibrillation. Risk. 2016;5(12.5):6.
30. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5. doi: 10.1001/jama.285.18.2370.
31. Bokma JP, Zegstroo I, Kuijpers JM, et al. Factors associated with coronary artery disease and stroke in adults with congenital heart disease. Heart. 2018;104(7):574-80. doi: 10.1136/heartjnl-2017-311620.
32. Deborath Lucia de Oliveira Diniz , Pedro Rodrigues Barreto, Pedro Felipe Carvalhedo de Bruin, et al. Wake-up stroke: Clinical characteristics, sedentary lifestyle, and daytime sleepiness. Rev Assoc Med Bras. 2016; 62(7):628-634. doi: 10.1590/1806-9282.62.07.628.
33. Basaraba J, Picard M, George-Phillips K, et al. Pharmacists as Care Providers for Stroke Patients: A Systematic Review. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 2018;45(1):49-55. doi:10.1017/cjn.2017.233.
34. Wang J, Wang J, Qiu S, et al. Pharmaceutical care program for ischemic stroke patients: a randomized controlled trial. Int J Clin Pharm. 2021. doi: 10.1007/s11096-021-01272-9.
35. Chen Q, Jin Z, Zhang P, et al. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China. Int J Clin Pharm. 2020;42(4):1237-41.